Skip to main content

Part of the book series: Psychiatrie der Gegenwart ((SPEZIELLE,volume 8))

Zusammenfassung

Substitutionsbehandlung ist eine Therapieform, bei welcher die Verschreibung abhängigkeitserzeugender Substanzen als Adjuvans im Rahmen der medizinischen und psychosozialen Betreuung eingesetzt wird. Indikation und Behandlungsdauer werden auf der Grundlage einer individuellen Abklärung festgesetzt.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Ali R, Auriacombe M, Casas M et al. (1998) Report of the external panel on the evaluation of the Swiss scientific studies of medically prescribed narcotics to drug addicts. WHO, Geneva

    Google Scholar 

  • Arif A, Westermeyer J (1990) Methadone maintenance in the management of opioid dependence. An international review. Praeger, New York

    Google Scholar 

  • Arndt JO, McLellan AT, Dorozynsky L, Woody GE, O’Brien CP (1994) Desipramine treatment for cocaine dependence. J Nerv Ment Dis 182:151–156

    Article  PubMed  CAS  Google Scholar 

  • Ball JC, Ross A (1991) The effectiveness of methadone maintenance treatment. Springer, Berlin Heidelberg New York Tokio

    Book  Google Scholar 

  • Bammer G, Dobler-Mikola A, Fleming PH, Strang , Uchtenhagen A (1999) The heroin prescribing debate: integrating science and politics. Science 284:1277–1278

    Article  PubMed  CAS  Google Scholar 

  • Batki SL, Washburu AM, Delucchi K, Jones RT (1996) A controlled trial of Fluoxetine in crack cocaine dependence. Drug Alcohol Depend 41:137–142

    Article  PubMed  CAS  Google Scholar 

  • Brüssel G van (1995) Le programme de distribution de morphine a Amsterdam: experiences pratiques. In: Rihs-Middel M, Clerc J, Stamm R (eds) La prescription de stupefiants sous contröle medical. Editions Medecine et Hygiene, Geneve, pp 161–167

    Google Scholar 

  • Bühringer G, Gastpar M, Heinz W et al. (1995) Methadon-Standards. Vorschläge zur Qualitätssicherung bei der Methadonsubstitution im Rahmen der Behandlung von Drogenabhängigen. Enke, Stuttgart

    Google Scholar 

  • Bundesamt für Gesundheit (1985) Methadonbericht. Suchtmittelersatz in der Behandlung Heroinabhängiger in der Schweiz. Bundesministerium für Gesundheit, Bern

    Google Scholar 

  • Caplehorn JR (1994) A comparison of abstinence-oriented and indefinite methadone maintenance treatment. Int J Addict 29:1361–1375

    PubMed  CAS  Google Scholar 

  • Chutuape MA. Silverman K, Stitzer ML (1998) Survey assessment of methadone treatment services reinforcers. Am J Drug Alcohol Abuse 29:1–16

    Article  Google Scholar 

  • Cooper JR, Altman F, Brown BS, Czechowicz D (1983) Research on the treatment of narcotic addiction. The State of the art. National Institute on Drug Abuse, Rockville

    Google Scholar 

  • Dees SM, Dansereau DF, Simpson DD (1997) Mapping-enhanced drug abuse counseling: urinalysis results in the first year of methadone treatment. J Subst Abuse Treat 14:45–54

    Article  PubMed  CAS  Google Scholar 

  • Dolan K, Hall W, Wodak A (1998) The provision of methadone within prison settings. In: Ward J, Mattick RP, Hall W (eds) Methadone maintenance treatment and other opioid replacement therapies. Harwood, Amsterdam, pp 379–396

    Google Scholar 

  • Dole V, Nyswander M (1965) A medical treatment for Diacetylmorphine (heroin) addiction. JAMA 193:146–150

    Article  Google Scholar 

  • Farrell M, Neeleman J, Gossop M, Griffiths P, Buning E, Finch E, Strang J (1996) Drug prevention. A review of the legislation, regulation and delivery of methadone in 12 member states of the European Union. Final Report. Office for Official Publications of the European Communities, Brüssels

    Google Scholar 

  • Finnegan LP, Hagan T, Kaltenbach KA (1991) Scientific foundation of clinical practice: opiate use in pregnant women. Bull NY Acad Med 67:223–239

    CAS  Google Scholar 

  • Gossop M (1998) NTORS at one year. The national treatment outcome research study. Department of Health, London

    Google Scholar 

  • Halikas JA, Nugent SM, Crosby RD, Carlson GA (1993) 1990-1991 survey of pharmacotherapies used in the treatment of cocaine abuse. J Addict Dis 12:129–139

    Article  PubMed  CAS  Google Scholar 

  • Hartnoll R, Mitcheson M, Battersby A, Brown G, Ellis M, Fleming P, Hedley N (1980) Evaluation of heroin maintenance in a controlled trial. Arch Gen Psychiatry 37:877–884

    Article  PubMed  CAS  Google Scholar 

  • Hubbard RL, Marsden ME, Rachal JV, Haarwood HJ, Cavanaugh ER, Ginzburg HM (1989) Drug abuse treatment. A national study of effectiveness. University of North Carolina, Chapel Hill

    Google Scholar 

  • Kreek MJ (1996) Long-term pharmacotherapy for opiate (primarily heroin) addiction: opioid agonists. In: Schuster CH, Kuhar MJ (eds) Pharmacological aspects of drug dependence. Toward an integrated neurobehavioral approach. Springer, Berlin Heidelberg New York Tokio, pp 487–562

    Google Scholar 

  • Lifschitz MH, Wilson GS, Smith EO, Desmond MM (1985) Factors affecting head growth and intellectual function in children of drug addicts. Pediatrics 75:269–274

    PubMed  CAS  Google Scholar 

  • Ling W, Klett JC, Gillis RC (1980) A cooperative clinical study of methadyl acetate. Arch Gen Psychiatry 37:908–911

    Article  PubMed  CAS  Google Scholar 

  • McLellan AT, Arndt IO, Metzger IS, Woody GE, O’Brien CP (1993) The effects of psychosocial services in substance abuse treatment. JAMA 269:1953–1959

    Article  PubMed  CAS  Google Scholar 

  • Maddux JF, Desmond DP, Esquivel M (1995) Rapid admission and retention on methadone. Am J Drug Alcohol Abuse 21:533–547

    Article  PubMed  CAS  Google Scholar 

  • Mattick RP, Oliphant D, Ward J, Hall W (1998) The effectiveness of other opioid replacement therapies: LAAM, heroin, buprenorphine, naltrexone and injectable maintenance. In: Ward J, Mattick RP, Hall W (eds) Methadone maintenance treatment and other opioid replacement therapies. Harwood, Amsterdam, pp 123–160

    Google Scholar 

  • Metrebian N, Shanahan W, Wells B, Stimson GV (1998) Feasibility of prescribing injectable heroin and methadone to opiate-dependent drug users: associated health gains and harm reductions. Med J Aust 168:596–600

    PubMed  CAS  Google Scholar 

  • Mino A (1990) Analyse scientifique de la literature sur la remise controlee d’heroine ou de morphine. Institutions universitaires de psychiatrie, Geneve

    Google Scholar 

  • Parrino MW (1991) State methadone treatment guidelines. US Department of Health and Human Services, Rockville

    Google Scholar 

  • Raschke P (1994) Substitutionstherapie. Ergebnisse langfristiger Behandlung von Opiatabhängigen. Lambertus, Freiburg im Breisgau

    Google Scholar 

  • Ree JM van (1998) Study on the effectiveness of medically co-prescribed heroin. Progress Report. Central Committee on the Treatment of Heroin Addicts, Utrecht

    Google Scholar 

  • Rhoades HM, Creson D, Elk R, Schmitz J, Grabowsk J (1998) Retention, HIV risk, and illicit drug use during treatment: methadone dose and visit frequency. Am J Public Health 88:34–39

    Article  PubMed  CAS  Google Scholar 

  • Robinson GM, Dukes PD, Robinson BJ, Cook RR, Mahoney GN (1993) The misuse of buprenorphine and buprenorphine-naloxone combination in Wellington, New Zealand. Drug Alcohol Depend 33:81–86

    Article  CAS  Google Scholar 

  • Ruel JM (1996) International survey on the use of methadone in the treatment of narcotic addiction. Bureau of Drug Surveillance, Ottawa

    Google Scholar 

  • Savage C, Karp EG, Curran SF, Hanion TE, McCabe OL (1976) Methadone/LAAM maintenance: a comparison study. Compr Psychiatry 17:415–424

    Article  PubMed  CAS  Google Scholar 

  • Seidenberg A, Honegger U (1998) Methadon, Heroin und andere Opioide. Medizinisches Manual für die ambulante opioidgestützte Behandlung. Huber, Bern

    Google Scholar 

  • Senay EC, Uchtenhagen A (1990) Methadone in the treatment of opioid dependence. In: Arif A, Westermeyer J (eds) Methadone maintenance in the management of opioid dependence. Praeger, New York, pp 19–54

    Google Scholar 

  • Senay EC, Barthwell A, Marks R, Bokos PJ (1994) Medical maintenance: an interim report. J Addict Dis 13:65–69

    Article  PubMed  CAS  Google Scholar 

  • Simpson £D, Seils SB (1990) Opioid addiction and treatment: a 12-year follow-up. Krieger, Malabar Simpson DD, Curry SJ (Eds) (1997) Drug abuse treatment outcome study DATOS. Psychol Addict Behav 11 (special issue)

    Google Scholar 

  • Simpson DD, Joe GW, Dansereau DF, Chatham LR (1997) Strategies for improving methadone treatment process and outcomes. J Drug Issues 27:239–260

    Google Scholar 

  • Stitzer ML, Iguchi MY, Felch LJ (1992) Contingent take-home incentive: effects on drug use of methadone. J Consult Clin Psychol 60:927–934

    Article  PubMed  CAS  Google Scholar 

  • Strang J, Gossop M (1996 ) Heroin prescribing in the British system: a historical review. Europ Addict Res 2:185–193

    Article  Google Scholar 

  • Svikis DS, Lee JH, Haug NA, Stitzer ML (1997) Attendance incentives for outpatient treatment: effects in methadone- and nonmethadone-maintained pregnant drug dependent women. Drug Alcohol Depend 48:33–41

    Article  PubMed  CAS  Google Scholar 

  • Tennant FS, Rawson RA, Pumphrey E, Seecof R (1986) Clinical experiences with 959 opioid-dependent patients treated with levo-alpha-acetylmethadol (LAAM). J Subst Abuse Treat 3:195–202

    Article  PubMed  Google Scholar 

  • Uchtenhagen A, Zimmer-Höfler D (1985) Heroinabhängige und ihre normalen Altersgenossen. Herkunft, Lebenssituation, Zweijahresverlauf im Quervergleich. Haupt, Bern

    Google Scholar 

  • Uchtenhagen A, Dobler-Mikola A, Steffen T, Gutzwiller F, Blättler R, Pfeifer S (1999) Prescription of narcotics for heroin addicts. Main results of the Swiss National Cohort Study. Karger, Basel

    Google Scholar 

  • Verthein U, Degkwitz P, Haasen C, Raschke P, Krausz M (1996) Die Substitutionsbehandlung Opiatabhängiger mit Codein/Dihydrocodein und Methadon - ein Kontrollgruppenvergleich. Sucht 42:108–115

    Google Scholar 

  • Walsh SL, Preston KL, Stitzer ML, Cone EJ, Bigelow GE (1994) Clinical pharmacology of buprenorphine. Ceiling effects at high doses . Clin Pharmacol Ther 55:569–580

    Article  PubMed  CAS  Google Scholar 

  • Ward J, Mattick R, Hall W (1998) Methadone maintenance treatment and other opioid replacement therapies. Harwood, Amsterdam

    Google Scholar 

  • Woody GE, McLellan AT, Luborsky LO, Brien CP (1995) Psychotherapy in Community methadone programs: a Validation study. Am J Psychiatry 152:1302–1308

    PubMed  CAS  Google Scholar 

  • WHO (1989) Options for the use of methadone in the treatment of drug dependence. WHO, Geneva

    Google Scholar 

  • WHO (1998) WHO expert committee on drug dependence, 3rd report. WHO, Geneva

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Uchtenhagen, A. (2000). Substitutionsbehandlung der Opiatabhängigkeit. In: Helmchen, H., Lauter, H., Henn, F., Sartorius, N. (eds) Erlebens- und Verhaltensstörungen, Abhängigkeit und Suizid. Psychiatrie der Gegenwart, vol 8. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-59627-8_23

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-59627-8_23

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-65803-0

  • Online ISBN: 978-3-642-59627-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics